Systematic IPP VS Symptomatic IPP in GERD Prevention After POEM for Achalasia. . A Comparative Retrospective Analysis
NCT ID: NCT04740437
Last Updated: 2021-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2017-01-01
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators wish to retrospectively compare patients who have received routine PPI therapy vs. patients who don't.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Physiotherapy on Post POEM Reflux
NCT05326113
Transoral Incisionless Fundoplication in Post-POEM GERD
NCT04770441
ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia
NCT04065516
Endoscopic Resection in Gastro-Esophageal Reflux Disease
NCT03357809
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
NCT06955520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent given
* Achalasia all types with eckhardt score \> 3
Exclusion Criteria
* Pregnant or breastfeeding woman
* Contraindication to PPIs
* Carrier of mediastinal and exogastric neoplasia
* Patient on PPIs prior to the procedure for indication that does not allow for their discontinuation
* Peptic esophagitis (Grade B, C or D) before or at the time of the procedure
* Previous treatment with Heller myotomy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine Debourdeau
Role: STUDY_DIRECTOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL21_0064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.